Li Mei, Duc Anne-Cécile E, Klosi Edvin, Pattabiraman Srividya, Spaller Mark R, Chow Christine S
Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA.
Biochemistry. 2009 Sep 8;48(35):8299-311. doi: 10.1021/bi900982t.
For almost five decades, antibiotics have been used successfully to control infectious diseases caused by bacterial pathogens. More recently, however, two-thirds of bacterial pathogens exhibit resistance and are continually evolving new resistance mechanisms against almost every clinically used antibiotic. Novel efforts are required for the development of new drugs or drug leads to combat these infectious diseases. A number of antibiotics target the bacterial aminoacyl-tRNA site (A site) of 16S rRNA (rRNA). Mutations in the A-site region are known to cause antibiotic resistance. In this study, a bacterial (Escherichia coli) A-site rRNA model was chosen as a target to screen for peptide binders. Two heptapeptides, HPVHHYQ and LPLTPLP, were selected through M13 phage display. Both peptides display selective binding to the A-site 16S rRNA with on-bead fluorescence assays. Dissociation constants (Kd's) of the amidated peptide HPVHHYQ-NH2 to various A-site RNA constructs were determined by using enzymatic footprinting, electrospray ionization mass spectrometry (ESI-MS), and isothermal titration calorimetry (ITC) under a variety of buffer and solution conditions. HPVHHYQ-NH2 exhibits moderate affinity for the A-site RNA, with an average Kd value of 16 microM. In addition, enzymatic footprinting assays and competition ESI-MS with a known A-site binder (paromomycin) revealed that peptide binding occurs near the asymmetric bulge at positions U1495 and G1494 and leads to increased exposure of residues A1492 and A1493.
近五十年来,抗生素一直成功用于控制由细菌病原体引起的传染病。然而,最近有三分之二的细菌病原体表现出耐药性,并且不断进化出新的耐药机制,几乎能抵抗每一种临床使用的抗生素。因此,需要做出新的努力来开发新药或药物先导物以对抗这些传染病。许多抗生素靶向16S核糖体RNA(rRNA)的细菌氨酰tRNA位点(A位点)。已知A位点区域的突变会导致抗生素耐药性。在本研究中,选择细菌(大肠杆菌)A位点rRNA模型作为筛选肽结合物的靶点。通过M13噬菌体展示筛选出了两种七肽,HPVHHYQ和LPLTPLP。通过珠上荧光测定法,这两种肽都对A位点16S rRNA表现出选择性结合。在各种缓冲液和溶液条件下,使用酶足迹法、电喷雾电离质谱(ESI-MS)和等温滴定量热法(ITC)测定了酰胺化肽HPVHHYQ-NH2与各种A位点RNA构建体的解离常数(Kd值)。HPVHHYQ-NH2对A位点RNA表现出中等亲和力,平均Kd值为16微摩尔。此外,酶足迹测定法以及与已知A位点结合剂(巴龙霉素)的竞争ESI-MS表明,肽结合发生在U1495和G1494位置的不对称凸起附近,并导致A1492和A1493残基的暴露增加。